These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1285697)

  • 1. [Evaluation of anti-atheromatous properties of calcium channel inhibitors].
    Drici MD; Coccoz F; Morand P; Lapalus P
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():161-5. PubMed ID: 1285697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers and atherosclerosis.
    Sowers JR
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):3-9. PubMed ID: 2220798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity.
    Hof RP; Rüegg UT
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):107S-113S. PubMed ID: 1826999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiatherosclerotic effects of calcium antagonists.
    Paoletti R; Bernini F; Corsini A; Soma MR
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S6-10. PubMed ID: 8852538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihypertensive therapy and vascular wall protection with special reference to calcium antagonists].
    Faulhaber HD
    Z Arztl Fortbild (Jena); 1993; 87(9 Suppl 5):1-5. PubMed ID: 8237075
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of calcium channel blockers on experimental hypercholesteremia in rabbits. Biochemical and histochemical study].
    Edelsteinová S; Lazarová Z; Lojda Z; Czirfusz A; Drábková E
    Cas Lek Cesk; 1991 Nov; 130(22-23):635-9. PubMed ID: 1786582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the mechanisms of the antiatherogenic effect of Ca-antagonists].
    Birou S
    Igaku Kenkyu; 1988 Apr; 58(2):77-84. PubMed ID: 3245408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium antagonists and development of the atheromatous plaque].
    Weber S
    Arch Mal Coeur Vaiss; 1997 May; 90 Spec No 2():51-3. PubMed ID: 9295927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological basis for use of calcium channel antagonists in hypertension.
    Scriabine A; Kazda S; Garthoff B; Nickerson PA
    Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and vascular smooth muscle cells in atherogenesis.
    Pauletto P; Sartore S; Giuriato L; Scatena M; Tonello M; Scannapieco G; Pessina AC; Dal Palù C
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S8-16. PubMed ID: 1377310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-atherosclerotic effects of calcium antagonists: a brief review.
    Henry PD
    Clin Invest Med; 1987 Nov; 10(6):601-5. PubMed ID: 3326699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists and atherosclerosis.
    Betz E; Weiss HD; Heinle H; Fotev Z
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S71-5. PubMed ID: 1725009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exacerbation of atherosclerosis induced by hypertensive and hypercholesterolemic states--potential mechanisms and therapeutic implications].
    Murakami T; Yamada N
    Nihon Rinsho; 1997 Aug; 55(8):2097-102. PubMed ID: 9284430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiatherosclerotic hopes of calcium channel blockers].
    Uetake Y; Shimosawa T
    Clin Calcium; 2005 Oct; 15(10):1689-94. PubMed ID: 16199916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers and the prevention of atherosclerosis.
    Gotto AM
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):342S-346S. PubMed ID: 2078321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits.
    Soma MR; Natali M; Donetti E; Baetta R; Farina P; Leonardi A; Comparato C; Barberi L; Catapano AL
    Br J Pharmacol; 1998 Dec; 125(7):1471-6. PubMed ID: 9884075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.